Abstract
In this study, 2-chloroquinolin-3-carbaldehyde 1 was used as a synthon for the synthesis of some new quinoline; pyrane; indeno[1,2-b]pyrano[2,3-b]quinoline heterocycles. The anti-inflammatory and analgesic activities of the synthesized compounds were evaluated using carrageenan-induced paw edema and writhing assays. The obtained data indicated that the majority of the tested compounds exhibited both analgesic and anti-inflammatory activities, particularly compounds 2 and 6 showed a comparable effect to a well known analgesic and anti-inflammatory, diclofenac sodium.
Keywords: Quinoline, Pyranes, Knoevenagel reaction, Analgesic, Anti-inflammatory, X-ray analysis, heterocyclic compounds, 2-chloroquinolin-3-carbaldehydes, synthon, benzoylacetonitrile, NMR spectrum, hot plate test, X-Ray Crystallography, water ad libitum, pyrazole residues
Letters in Drug Design & Discovery
Title: New Quinoline-Based Compounds for Analgesic and Anti-Inflammatory Evaluation
Volume: 8 Issue: 7
Author(s): Rizk Elsayed Khidre, Bakr Fathy Abdel-Wahab and Farid Abdel-Rehem Badria
Affiliation:
Keywords: Quinoline, Pyranes, Knoevenagel reaction, Analgesic, Anti-inflammatory, X-ray analysis, heterocyclic compounds, 2-chloroquinolin-3-carbaldehydes, synthon, benzoylacetonitrile, NMR spectrum, hot plate test, X-Ray Crystallography, water ad libitum, pyrazole residues
Abstract: In this study, 2-chloroquinolin-3-carbaldehyde 1 was used as a synthon for the synthesis of some new quinoline; pyrane; indeno[1,2-b]pyrano[2,3-b]quinoline heterocycles. The anti-inflammatory and analgesic activities of the synthesized compounds were evaluated using carrageenan-induced paw edema and writhing assays. The obtained data indicated that the majority of the tested compounds exhibited both analgesic and anti-inflammatory activities, particularly compounds 2 and 6 showed a comparable effect to a well known analgesic and anti-inflammatory, diclofenac sodium.
Export Options
About this article
Cite this article as:
Elsayed Khidre Rizk, Fathy Abdel-Wahab Bakr and Abdel-Rehem Badria Farid, New Quinoline-Based Compounds for Analgesic and Anti-Inflammatory Evaluation, Letters in Drug Design & Discovery 2011; 8 (7) . https://dx.doi.org/10.2174/157018011796235194
DOI https://dx.doi.org/10.2174/157018011796235194 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Impact of the Vaccination Against COVID-19 on Frontline Health Workers
Current Drug Safety The Topology of Molecule and Its Lipophilicity
Current Computer-Aided Drug Design Peptide-based Vaccines in the Treatment of Specific Allergy
Current Drug Targets - Inflammation & Allergy Molecular Modeling Targeting Transmembrane Serine Protease 2 (TMPRSS2) as an Alternative Drug Target Against Coronaviruses
Current Drug Targets Specific Recognition of DNA by Small Molecules
Current Medicinal Chemistry Iron Oxide Nano Particles and its Applications to Cure HER2-Positive Mediated Breast Cancer
Current Nanomedicine Parenchymal Injuries
Current Respiratory Medicine Reviews Significant Breakthroughs in Search for Anti-Infectious Agents Derived from Erythromycin A
Current Medicinal Chemistry PI3K-Akt Signaling and Viral Infection
Recent Patents on Biotechnology BCG Vaccination Program Mitigates COVID19 Related Mortality: A Reality Check
Current Pharmaceutical Biotechnology Thiazole Containing Nitrogen Mustards: Synthesis, Structural Evaluation, Cytotoxicity and DNA Binding Studies
Letters in Drug Design & Discovery Anti-Diabetic Drugs GLP-1 Agonists and DPP-4 Inhibitors may Represent Potential Therapeutic Approaches for COVID-19
Endocrine, Metabolic & Immune Disorders - Drug Targets Bioactive Metabolites from Pathogenic and Endophytic Fungi of Forest Trees
Current Medicinal Chemistry Chitosan Oligomer and Zinc Oxide Nanoparticles for Treating Wastewaters: US20190134086 Patent Evaluation
Recent Patents on Biotechnology Strategies for the Design of Potent and Selective Kinase Inhibitors
Current Pharmaceutical Design Chitosan Nanoparticles: A Therapeutic Carrier for Delivery of DNA, siRNA and CpG-ODNs
Nanoscience & Nanotechnology-Asia Withdrawal Notice: Lead Optimization from Natural Ligands by In-Silico Approach for Discovering Potential Monoamine Oxidasesinhibitors (MAOIs)
Current Drug Metabolism Novel Trifluoromethylpyrazole Acyl Thiourea Derivatives: Synthesis, Antifungal Activity and Docking Study
Letters in Drug Design & Discovery Advanced In Silico Approaches for Drug Discovery: Mining Information from Multiple Biological and Chemical Data Through mtk- QSBER and pt-QSPR Strategies
Current Medicinal Chemistry Computational Biology and Drug Discovery: From Single-Target to Network Drugs
Current Bioinformatics